Appointments

Oragenics, Inc., a biotech company that fights infectious diseases including coronaviruses, has announced appointment of Kimberly M. Murphy, member of the Board of Directors, as President and Chief Executive Officer effective June 23, 2022. Murphy brings more than 25 years of vaccine industry experience at leading pharmaceutical companies including serving as a key leader in [...]

Althea UK & Ireland – the leading MES and medical equipment service provider – is pleased to announce that Mark Graves has been appointed as its new Operations Director. Mark will start on Monday 27th June, joining three other UK Directors making up Althea’s UK board. As Operations Director, Mark will oversee the delivery of Althea’s [...]

Scottish Health Innovations Limited (SHIL) has made two strategic hires as the organisation continues to bolster its team amid the build-up to its 20th anniversary. Leigh Mair has been appointed as Innovation Manager for North Scotland and the Scottish Islands, while Uma Shanmugam takes up the position of Regulatory Manager. Both arrive ahead of a [...]

ONWARD Medical N.V., the medical technology company creating therapies to restore movement, independence and health in people with spinal cord injury, has announced the appointment of Kristina Dziekan to its Board of Directors. Dziekan is currently Head of Market Access, Government Affairs and Tendering for Alcon’s Surgical Division in Europe. She previously served as Senior [...]

Alpine Immune Sciences, Inc., a clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, has announced the appointment of industry veteran Andrew S. Sandler, M.D., as its Chief Medical Officer. Dr. Sandler joins Alpine from Kiadis Pharma, a Sanofi Company, where he was Chief Medical Officer. Dr. Sandler’s anticipated [...]

SQZ Biotechnologies, focused on unlocking the full potential of cell therapies for multiple therapeutic areas, has appointed Marshelle Smith Warren, M.D., as Chief Medical Officer. Dr Warren will report to the CEO and lead the company’s clinical development, clinical operations, translational medicine and regulatory affairs functions. “Marshelle has extensive experience in cell-based therapeutic development and [...]

CN Bio, an Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), has announced the appointment of Dr Paul Brooks as Chief Business Officer. Brooks will be responsible for shaping the company’s commercial business strategy and leading the expansion of its global commercial organisation. Brooks is an experienced C-suite level executive [...]

Swiss next generation proteomics company Biognosys has announced the appointment of Beat Lüthi, Ph.D., as Board Director. Dr. Lüthi is Chief Executive Officer of CTC Analytics AG, a privately owned Swiss company leading in automation and advanced laboratory sample handling solutions for the pharmaceutical, life science, chemical, environmental, and food & flavour industries. Additionally, he [...]

Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment of Nora Brennan as Chief Financial Officer effective May 25, 2022. Brennan has served on Spectrum’s Board of Directors and as Chairperson of the Audit Committee since December 2020, and will relinquish her Board duties to assume this new [...]

Emerging pre-clinical stage biotech company BriOri BioTech has announced the appointment of Gordon Robert Alton, PhD as COO. BriOri is focused on developing a pipeline of opiate-free topical pain medications, including the topical reformulation of oral medication, Vioxx. The COX-2 specific NSAID aims to alleviate osteoarthritis related pain of the knee and joints. Bruce Register, [...]